Skip to main content

Table 1 Characteristics of the study population

From: The association and predictive value analysis of metabolic syndrome on diastolic heart failure in patients at high risk for coronary artery disease

Variable

Total (n = 261)

Non-MetS (n = 48)

Pre-MetS (n = 149)

MetS (n = 64)

p value

Age

59.56 ± 14.53

51.27 ± 14.45

59.68 ± 14.4

65.48 ± 11.85

<0.001

Gender (male, %)

153(58.6%)

25(52.1%)

89(59.7%)

39(60.9%)

0.588

Height

165.83 ± 8.11

165.1 ± 8.45

165.95 ± 7.77

166.08 ± 8.71

0.789

Weight

65.11 ± 11.74

58.55 ± 8.49

63.63 ± 10.87

73.47 ± 11.34

<0.001

BMI

23.56 ± 3.54

21.38 ± 2.08

22.97 ± 3.29

26.55 ± 3.11

<0.001

WC

82.92 ± 7.82

77.97 ± 6.213

82 ± 7

87.04 ± 7.19

<0.001

SBP

128 ± 18

116 ± 11

128 ± 18

136 ± 18

<0.001

DBP

76 ± 11

72 ± 7

76 ± 11

81 ± 13

<0.001

HR

71 ± 11

66 ± 11

72 ± 11

73 ± 12

0.007

Laboratory assay

FPG

6.02 ± 2.52

4.83 ± 0.26

6.11 ± 2.88

6.73 ± 2.25

<0.001

PBG

8.48 ± 4.08

6.24 ± 0.83

8.4 ± 4.25

9.66 ± 4.32

0.004

HbAlc

6.74 ± 2.13

5.23 ± 0.42

6.91 ± 2.36

7.16 ± 1.97

0.003

TC

4.5 ± 1.12

4.21 ± 0.81

4.59 ± 1.13

4.49 ± 1.26

0.142

TG

1.61 ± 1.2

0.98 ± 0.33

1.49 ± 0.95

2.34 ± 1.68

<0.001

HDL

1.14 ± 0.3

1.3 ± 0.28

1.16 ± 0.3

0.99 ± 0.23

<0.001

LDL

2.56 ± 0.89

2.31 ± 0.67

2.67 ± 0.92

2.49 ± 0.91

0.048

Cr

76.11 ± 25.93

68.04 ± 14.06

74.84 ± 22.45

84.78 ± 35.96

0.002

Ccr

85.58 ± 30.31

91.04 ± 24

85.46 ± 31.27

81.95 ± 31.97

0.300

UA

0.34 ± 0.1

0.3 ± 0.08

0.34 ± 0.1

0.38 ± 0.12

0.001

Echocardiographic measurement

LVEF (%)

65 ± 6

65 ± 4

66 ± 4

65 ± 6

0.426

DT

217.29 ± 56.37

196.67 ± 43.63

214.3 ± 59.54

239.7 ± 50.12

<0.001

LAD

36.17 ± 4.81

33.67 ± 4.07

35.7 ± 4.45

39.14 ± 4.75

<0.001

LVMI

112.77 ± 35.91

98.51 ± 28.23

108.46 ± 35.72

133.71 ± 33

<0.001

DHF (yes, %)

137(52.5%)

10(20.80%)

78(52.3%)

49(76.6%)

<0.001

Past medical history (yes, %)

CAD

79(30.3%)

6(12.5%)

41(27.5%)

32(50%)

<0.001

HT

155(59.4%)

0(0.0%)

95(63.8%)

60(93.8%)

<0.001

DM

102(39.1%)

0(0.0%)

58(38.9%)

44(68.8%)

<0.001

Smoking

75(28.7%)

14(29.2%)

49(32.9%)

12(18.8%)

0.106

Medical therapy (yes, %)

Anti-hypertension

140(53.6%)

0(0.0%)

85(57%)

55(85.9%)

<0.001

Hypoglycaemic

78(29.9%)

0(0.0%)

45(30.2%)

33(51.6%)

<0.001

Anti-lipids

69(26.4%)

5(10.41%)

41(27.5%)

23(35.9%)

0.009

  1. Note: BMI Body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, MetS metabolic syndrome, HT Hypertension, DM Diabetes, FPG fasting plasma glucose, PBG plasma blood glucose, HbA1c glycated hemoglobin, TC serum total cholesterol, HDL high-density lipoprotein cholesterol, TG triglyceride, UA uric acid, LDL low density lipoprotein cholesterol, Ccr creatinine clearance rate, Cr creatinine, LVMI left ventricular mass index, LAD left atrial diameter, DT deceleration time, LVEF left ventricular ejection fraction.
Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us